Work

Figure S1 from Therapeutic Targeting of DGKA-Mediated Macropinocytosis Leads to Phospholipid Reprogramming in Tuberous Sclerosis Complex

Year: 2023

Type: other

Abstract: Ritanserin inhibits the proliferation of multiple TSC2-deficient cell lines, independently of autophagy.

DOI: 10.1158/0008-5472.22429972.v1

Authors: Andrii Kovalenko, Andres Sanin, Kosmas Kosmas, Long Zhang, Ji Wang, Elie W. Akl, Krinio Giannikou, Clemens K. Probst, Thomas R. Hougard, Ryan W. Rue, Vera P. Krymskaya, John M. Asara, Hilaire C. Lam, David J. Kwiatkowski, Elizabeth P. Henske, Harilaos Filippakis

Language: English

Topic: Tuberous Sclerosis Complex Research

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361867754

Cites:

Cited by:

Related to: 10